| [1] | Lu J.Y., Tu W.B., Li R., et al. (2025). Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming. Cell 188:5895−5911.e5817. DOI:10.1016/j.cell.2025.07.031 |
| [2] | Youssef K.K. and Nieto M.A. (2024). Epithelial–mesenchymal transition in tissue repair and degeneration. Nat. Rev. Molecul. Cell Biol. 25:720−739. DOI:10.1038/s41580-024-00733-z |
| [3] | Zhang B., Lee D.E., Trapp A., et al. (2023). Multi-omic rejuvenation and life span extension on exposure to youthful circulation. Nat. Aging 3:948−964. DOI:10.1038/s43587-023-00451-9 |
| [4] | Browder K.C., Reddy P., Yamamoto M., et al. (2022). In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nat. Aging 2:243−253. DOI:10.1038/s43587-022-00183-2 |
| [5] | Dai J., Xu H., Chen T., et al. (2025). Artificial intelligence for medicine 2025: Navigating the endless frontier. Innov. Med. 3:100120. DOI:10.59717/j.xinn-med.2025.100120 |
| Zhang Y., Chen Q., Li F., et al. (2026). Reversing mesenchymal drift in organismal decline: A new mandate for partial reprogramming. The Innovation Medicine 4:100241. https://doi.org/10.59717/j.xinn-med.2026.100241 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Partial reprogramming reverses MD during organ aging and disease progression